{
    "eid": "2-s2.0-85161010875",
    "title": "Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "asthma",
        "biologics",
        "CRSwNP",
        "double treatment",
        "switching"
    ],
    "authors": [
        "Josje Otten",
        "Rik van der Lans",
        "Eugenio de Corso",
        "kanstantsin Dziadziulia",
        "Bart Hilvering",
        "Els Weersink",
        "Matteo Bonini",
        "Jan Hagemann",
        "Wanrawee Thaitrakool",
        "Claudio Montuori",
        "Ludger Klimek",
        "Sietze Reitsma",
        "Wytske Fokkens"
    ],
    "citedby-count": 0,
    "ref-count": 18,
    "ref-list": [
        "EPOS 4 Patients",
        "The EUFOREA pocket guide for chronic rhinosinusitis",
        "European position paper on rhinosinusitis and nasal polyps 2020",
        "Global variability in administrative approval prescription criteria for biologic therapy in severe asthma",
        "Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines",
        "Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma",
        "Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps",
        "Effectiveness of dupilumab in the treatment of patients with severe uncontrolled CRSwNP: a \u201cReal-life\u201d observational study in the first year of treatment",
        "Real world biologic use and switch patterns in severe asthma: data from the international severe asthma registry and the US CHRONICLE study",
        "Relight: a two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asThma in Greece: evaluating the multiple components of response",
        "Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment",
        "Benralizumab rapidly improves asthma control in Austrian real-life severe eosinophilic asthmatics",
        "Controversies in allergy: choosing a biologic for patients with severe asthma",
        "Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps",
        "Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Ralpha in a real-world setting",
        "Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis",
        "Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: a Bayesian network meta-analysis",
        "Safety of combining biologics in severe asthma: asthma-related and unrelated combinations"
    ],
    "affiliation": [
        {
            "affiliation-city": "Rome",
            "@id": "60031984",
            "affilname": "Universit\u00e0 Cattolica del Sacro Cuore, Campus di Roma",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031984",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Rome",
            "@id": "60073799",
            "affilname": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073799",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Mainz",
            "@id": "60022135",
            "affilname": "Universit\u00e4tsmedizin Mainz",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022135",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Amsterdam",
            "@id": "60002483",
            "affilname": "Universiteit van Amsterdam",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002483",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Amsterdam",
            "@id": "122818768",
            "affilname": "Amsterdam UMC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122818768",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Wiesbaden",
            "@id": "112607885",
            "affilname": "Center for Rhinology and Allergology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112607885",
            "affiliation-country": "Germany"
        }
    ],
    "funding": []
}